You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

89 Results
Guidelines and Advice
Status: Archived
ID: CED 15
Nov 2009
Guidelines and Advice
Status: Education and Information
ID: 6-16 Version 2
Version: 2
Feb 2014
Drug
Other Name(s): Venclexta®
May 2024
Drug
Other Name(s): Zydelig™
Feb 2022
Drug
Other Name(s): Gazyva®
May 2022
Drug
Other Name(s): Brukinsa®
Apr 2024
Guidelines and Advice
Drug
Other Name(s): Treanda®
Nov 2024
Drug
Other Name(s): Imbruvica®
Feb 2023
Regimen
Cancer Type:
Hematologic, 
Leukemia - Chronic Lymphocytic (CLL), 
Lymphoma - Non-Hodgkin's Intermediate Grade, 
Lymphoma - Non-Hodgkin's Low Grade, 
Multiple Myeloma
Intent: Palliative
Funding:
ODB - General Benefit
    cyclophosphamide - oral tablets
May 2019
Drug
Other Name(s): Fludara®
Apr 2023
Regimen
Cancer Type:
Hematologic, 
Leukemia - Chronic Lymphocytic (CLL), 
Lymphoma - Non-Hodgkin's High Grade, 
Lymphoma - Non-Hodgkin's Intermediate Grade, 
Lymphoma - Non-Hodgkin's Low Grade
Intent: Palliative
Funding:
ODB - General Benefit
    chlorambucil
ODB - General Benefit
    prednisone
May 2019

Pages